See more : Augean plc (AUG.L) Income Statement Analysis – Financial Results
Complete financial analysis of Parkway Life Real Estate Investment Trust (PRKWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Parkway Life Real Estate Investment Trust, a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
- Investeringsforeningen Wealth Invest – Forskel – Bæredygtige Aktier (WEIFBA.CO) Income Statement Analysis – Financial Results
- Aqaseem Factory for Chemicals and Plastics Co. (9539.SR) Income Statement Analysis – Financial Results
- Calfrac Well Services Ltd. (CFWWF) Income Statement Analysis – Financial Results
- Wooshin Systems Co., Ltd. (017370.KS) Income Statement Analysis – Financial Results
- Raffles Education Corporation Limited (NR7.SI) Income Statement Analysis – Financial Results
Parkway Life Real Estate Investment Trust (PRKWF)
About Parkway Life Real Estate Investment Trust
Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices). PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020. It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan. It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 147.47M | 129.97M | 120.71M | 120.89M | 115.22M | 112.84M | 109.88M | 110.12M | 102.69M | 100.38M | 93.69M | 94.07M | 87.76M | 80.05M | 66.68M | 53.89M | 16.90M |
| Cost of Revenue | 22.67M | 8.10M | 9.47M | 8.36M | 7.00M | 7.43M | 7.23M | 7.70M | 6.70M | 6.61M | 6.09M | 7.65M | 7.46M | 6.42M | 4.70M | 3.53M | 1.09M |
| Gross Profit | 124.80M | 121.87M | 111.23M | 112.53M | 108.23M | 105.40M | 102.65M | 102.43M | 96.00M | 93.78M | 87.60M | 86.43M | 80.31M | 73.63M | 61.98M | 50.36M | 15.81M |
| Gross Profit Ratio | 84.63% | 93.76% | 92.15% | 93.08% | 93.93% | 93.41% | 93.42% | 93.01% | 93.48% | 93.42% | 93.50% | 91.87% | 91.51% | 91.98% | 92.96% | 93.45% | 93.56% |
| Research & Development | 0.00 | 0.36 | 2.78 | 0.80 | 1.15 | 1.41 | 1.00 | 0.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.01M | 16.09M | 15.29M | 15.51M | 11.88M | 11.40M | 11.15M | 11.11M | 10.41M | 10.05M | 9.38M | 8.27M | 10.50M | 9.39M | 8.48M | 7.38M | 622.00K |
| Selling & Marketing | 206.00K | 4.00K | 45.00K | 8.00K | 0.00 | 14.00K | 17.00K | 282.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.21M | 16.09M | 15.29M | 15.51M | 11.88M | 11.40M | 11.15M | 11.11M | 10.41M | 10.05M | 9.38M | 8.27M | 10.50M | 9.39M | 8.48M | 7.38M | 622.00K |
| Other Expenses | 0.00 | 2.45M | 1.37M | -1.22M | -316.00K | 71.15M | 19.60M | 13.64M | 210.00K | 140.00K | 176.00K | 98.00K | 112.00K | 0.00 | 0.00 | 0.00 | 55.94M |
| Operating Expenses | 3.21M | 17.08M | 16.23M | 16.39M | 14.96M | 14.59M | 14.24M | 13.98M | 13.05M | 12.79M | 11.85M | 10.52M | 10.50M | 9.39M | -20.82M | 7.38M | 2.21M |
| Cost & Expenses | 25.88M | 25.18M | 25.70M | 24.75M | 21.95M | 22.02M | 21.47M | 21.68M | 19.74M | 19.39M | 17.94M | 18.17M | 17.95M | 15.81M | -16.12M | 10.91M | 3.29M |
| Interest Income | 2.17M | 1.29M | 322.00K | 843.00K | 10.00K | 6.00K | 4.00K | 11.00K | 6.00K | 6.00K | 10.00K | 18.00K | 31.00K | 34.00K | 177.00K | 94.00K | |
| Interest Expense | 12.93M | 6.10M | 4.17M | 5.34M | 5.92M | 6.07M | 9.04M | 7.91M | 7.36M | 6.70M | 7.67M | 8.86M | 11.05M | 7.94M | 3.99M | 1.00M | |
| Depreciation & Amortization | 121.00K | 21.23M | 22.64M | 25.75M | 26.13M | 31.01M | 27.47M | 33.50M | -82.95M | -80.99M | -75.75M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 121.20M | 112.14M | 344.92M | 101.73M | 139.50M | 166.78M | 117.07M | 111.13M | 0.00 | 72.78M | 0.00 | 124.40M | 116.78M | 82.83M | 82.80M | 31.63M | 69.64M |
| EBITDA Ratio | 82.19% | 37.82% | 278.07% | 84.83% | 117.59% | 149.81% | 104.77% | 100.91% | 88.53% | 140.60% | 115.32% | 132.24% | 133.06% | 103.47% | 124.18% | 58.70% | 412.07% |
| Operating Income | 121.08M | 49.16M | 335.65M | 102.55M | 135.48M | 169.04M | 115.12M | 111.13M | 90.92M | 141.14M | 108.05M | 124.40M | 116.78M | 82.83M | 82.80M | 31.63M | 69.64M |
| Operating Income Ratio | 82.11% | 37.82% | 278.07% | 84.83% | 117.59% | 149.81% | 104.77% | 100.91% | 88.53% | 140.60% | 115.32% | 132.24% | 133.06% | 103.47% | 124.18% | 58.70% | 412.07% |
| Total Other Income/Expenses | -12.81M | -56.58M | 245.74M | 247.00K | 39.29M | 70.36M | 21.76M | 12.05M | -3.82M | -7.32M | -3.46M | 49.40M | 44.95M | 14.69M | 28.73M | -3.82M | 56.39M |
| Income Before Tax | 108.27M | 48.22M | 340.75M | 96.39M | 132.00M | 160.71M | 109.97M | 100.17M | 78.93M | 133.81M | 104.59M | 121.56M | 107.52M | 72.38M | 74.90M | 25.42M | 68.64M |
| Income Before Tax Ratio | 73.42% | 37.10% | 282.30% | 79.73% | 114.56% | 142.43% | 100.08% | 90.97% | 76.86% | 133.30% | 111.63% | 129.21% | 122.51% | 90.42% | 112.33% | 47.16% | 406.14% |
| Income Tax Expense | 7.80M | 7.08M | 8.87M | 9.17M | 8.61M | 8.78M | 8.50M | 8.25M | 11.94M | 12.71M | 6.31M | 6.15M | 5.48M | 7.32M | 1.96M | 719.00K | 0.00 |
| Net Income | 100.47M | 41.14M | 331.88M | 87.22M | 123.40M | 151.93M | 101.46M | 91.93M | 66.99M | 121.11M | 98.28M | 115.41M | 102.04M | 65.05M | 72.94M | 24.70M | 68.64M |
| Net Income Ratio | 68.13% | 31.65% | 274.95% | 72.15% | 107.09% | 134.65% | 92.34% | 83.48% | 65.23% | 120.65% | 104.89% | 122.68% | 116.27% | 81.27% | 109.39% | 45.83% | 406.14% |
| EPS | 0.17 | 0.07 | 0.55 | 0.14 | 0.20 | 0.25 | 0.17 | 0.15 | 0.11 | 0.20 | 0.16 | 0.19 | 0.17 | 0.11 | 0.12 | 0.04 | 0.15 |
| EPS Diluted | 0.17 | 0.07 | 0.55 | 0.14 | 0.20 | 0.25 | 0.17 | 0.15 | 0.11 | 0.20 | 0.16 | 0.19 | 0.17 | 0.11 | 0.12 | 0.04 | 0.15 |
| Weighted Avg Shares Out | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 604.97M | 604.38M | 603.28M | 602.01M | 455.41M |
| Weighted Avg Shares Out (Dil) | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.00M | 605.01M | 605.00M | 605.00M | 605.00M | 604.97M | 604.38M | 603.28M | 602.01M | 455.41M |
Source: https://incomestatements.info
Category: Stock Reports